UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: A pooled analysis of 3 clinical trials

The American heart journal, 2014-06, Vol.167 (6), p.853-860.e4

2014

Volltextzugriff (PDF)

Plasma Galectin-3 and Heart Failure Outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)

Journal of cardiac failure, 2014-11, Vol.20 (11), p.793-799

2014

Volltextzugriff (PDF)

Lipidomic profiling identifies signatures of metabolic risk

EBioMedicine, 2020-01, Vol.51, p.102520, Article 102520

2020

Volltextzugriff (PDF)

Risk Factors for Near-Term Myocardial Infarction in Apparently Healthy Men and Women

Clinical chemistry (Baltimore, Md.), 2010-04, Vol.56 (4), p.559-567

2010

Volltextzugriff (PDF)

Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers

PloS one, 2014-11, Vol.9 (11), p.e112835-e112835

2014

Volltextzugriff (PDF)

Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study

JACC. Cardiovascular imaging, 2012-07, Vol.5 (7), p.681-689

2012

Volltextzugriff (PDF)

DNA Typing in Thirty Seconds with a Microfabricated Device

Proceedings of the National Academy of Sciences - PNAS, 1997-09, Vol.94 (19), p.10273-10278

1997

Volltextzugriff (PDF)

Carotid Plaque Burden as a Measure of Subclinical Atherosclerosis

JACC. Cardiovascular imaging, 2012-07, Vol.5 (7), p.681-689

2012

Volltextzugriff (PDF)

Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT

European journal of heart failure, 2013-05, Vol.15 (5), p.511-518

2013

Volltextzugriff (PDF)

Plasma Galectin-3 Is Associated with Near-Term Rehospitalization in Heart Failure: A Meta-Analysis

Journal of cardiac failure, 2011, Vol.17 (8), p.S93-S93

2011

Volltextzugriff (PDF)

Changes in Galectin-3 Levels over Time Predict Mortality and Morbidity in Chronic HF

Journal of cardiac failure, 2011, Vol.17 (8), p.S92-S92

2011

Volltextzugriff (PDF)

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH

Circulation. Heart failure, 2013-03, Vol.6 (2), p.219-226

2013

Volltextzugriff (PDF)

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

European heart journal, 2012-09, Vol.33 (18), p.2290-2296

2012

Volltextzugriff (PDF)

Multiple imputation and analysis for high-dimensional incomplete proteomics data

Statistics in medicine, 2016-04, Vol.35 (8), p.1315-1326

2016

Volltextzugriff (PDF)

Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative

Arteriosclerosis, thrombosis, and vascular biology, 2014-04, Vol.34 (4), p.939-945

2014

Volltextzugriff (PDF)

Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure

Clinical biochemistry, 2010-05, Vol.43 (7-8), p.683-690

2010

Volltextzugriff (PDF)

Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes

The journal of clinical endocrinology and metabolism, 2016-04, Vol.101 (4), p.1779-1789

2016

Volltextzugriff (PDF)

Abstract 18728: Discovery Lipidomic and Metabolomic Profiling Predicts Longitudinal Changes in Metabolic Risk Factors

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Volltextzugriff (PDF)

Semi-Targeted Plasma Proteomics Discovery Workflow Utilizing Two-Stage Protein Depletion and Off-Line LC−MALDI MS/MS

Journal of proteome research, 2011-01, Vol.10 (1), p.34-45

2011

Volltextzugriff (PDF)

DNA Sequencing on Microfabricated Electrophoretic Devices

Analytical chemistry (Washington), 1998-06, Vol.70 (11), p.2303-2310

1998

Volltextzugriff (PDF)

Abstract 37: Metabolomic Signatures of Metabolic Risk Factors for Atherosclerotic Cardiovascular Disease

Arteriosclerosis, thrombosis, and vascular biology, 2012-05, Vol.32 (suppl_1)

2012

Volltextzugriff (PDF)

Time dependent changes in myocardial proteins of the porcine left ventricle during pressure overload

The FASEB journal, 2012-04, Vol.26 (S1)

2012

Volltextzugriff (PDF)

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) : Genetic and protein markers of CVD

European heart journal, 2012, Vol.33 (18), p.2290-2296

2012

Volltextzugriff (PDF)

Optimization of High-Performance DNA Sequencing on Short Microfabricated Electrophoretic Devices

Analytical chemistry (Washington), 2000-07, Vol.72 (14), p.3129-3137

2000

Volltextzugriff (PDF)

Correlation network analysis for data integration and biomarker selection

Molecular bioSystems, 2008-01, Vol.4 (3), p.249

2008

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: A pooled analysis of 3 clinical trials

Plasma Galectin-3 and Heart Failure Outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)

Lipidomic profiling identifies signatures of metabolic risk

Risk Factors for Near-Term Myocardial Infarction in Apparently Healthy Men and Women

Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers

Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study

DNA Typing in Thirty Seconds with a Microfabricated Device

Carotid Plaque Burden as a Measure of Subclinical Atherosclerosis

Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT

Plasma Galectin-3 Is Associated with Near-Term Rehospitalization in Heart Failure: A Meta-Analysis

Changes in Galectin-3 Levels over Time Predict Mortality and Morbidity in Chronic HF

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Multiple imputation and analysis for high-dimensional incomplete proteomics data

Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative

Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure

Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes

Abstract 18728: Discovery Lipidomic and Metabolomic Profiling Predicts Longitudinal Changes in Metabolic Risk Factors

Semi-Targeted Plasma Proteomics Discovery Workflow Utilizing Two-Stage Protein Depletion and Off-Line LC−MALDI MS/MS

DNA Sequencing on Microfabricated Electrophoretic Devices

Abstract 37: Metabolomic Signatures of Metabolic Risk Factors for Atherosclerotic Cardiovascular Disease

Time dependent changes in myocardial proteins of the porcine left ventricle during pressure overload

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) : Genetic and protein markers of CVD

Optimization of High-Performance DNA Sequencing on Short Microfabricated Electrophoretic Devices

Correlation network analysis for data integration and biomarker selection

Suchergebnisse filtern